<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>dasatinib &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/dasatinib/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Thu, 08 Oct 2026 06:37:46 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>dasatinib &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Senolytic Drugs Show Promise Against Bone Loss Caused by Chemotherapy</title>
		<link>https://bioengineer.org/senolytic-drugs-show-promise-against-bone-loss-caused-by-chemotherapy/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Thu, 08 Oct 2026 06:37:46 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[bone marrow adiposity]]></category>
		<category><![CDATA[bone proteomics]]></category>
		<category><![CDATA[Cellular Senescence]]></category>
		<category><![CDATA[chemotherapy-induced bone loss]]></category>
		<category><![CDATA[dasatinib]]></category>
		<category><![CDATA[doxorubicin]]></category>
		<category><![CDATA[GeroScience]]></category>
		<category><![CDATA[osteoblasts]]></category>
		<category><![CDATA[osteoporosis]]></category>
		<category><![CDATA[quercetin]]></category>
		<category><![CDATA[SASP]]></category>
		<category><![CDATA[senolytics]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=406914</guid>

					<description><![CDATA[A new mouse study shows that senolytic drugs targeting senescent cells can partially mitigate the bone loss and marrow fat accumulation caused by doxorubicin chemotherapy, with effects that vary by age and sex.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">406914</post-id>	</item>
	</channel>
</rss>
